本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mira Pharma

0.8501
-0.0149-1.72%
成交量:11.12万
成交额:9.45万
市值:1,429.33万
市盈率:-1.67
高:0.8864
开:0.8500
低:0.8400
收:0.8650
数据加载中...
2023/12/19

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/12/01

重要事件披露

Form 8-K - Current report
2023/11/20

重要事件披露

Form 8-K - Current report
2023/11/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/16

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/14

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/08

重要事件披露

Form 8-K - Current report
2023/07/31

SEC问询函

Form CORRESP - Correspondence
2023/07/31

SEC问询函

Form CORRESP - Correspondence
2023/07/29

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/21

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/18

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/14

SEC问询函

Form CORRESP - Correspondence
2023/07/14

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/13

SEC问询函

Form CORRESP - Correspondence